September 1, 2003

1 Min Read
Top Medtech Firms Post Strong 2Q Gains

Originally Published MXSeptember/October 2003


Reported revenues for top-earning publicly traded medical technology companies for April through June 2003 (2Q03) versus April through June 2002 (2Q02). Only divisions reporting medical product revenues are included; pharmaceutical, consumer-product, and healthcare services are excluded. All figures in $ millions at July 2003 rate. Order is by FY02 annual revenues, from most to least (Click to enlarge).

Top-earning publicly held medtech companies are continuing to show why investors should be paying more attention to the industry. In earnings reports issued since the end of June, nine of industry's top-20 public companies have announced second-quarter results reflecting double-digit revenue increases over the same period last year.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like